Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response

被引:18
作者
Nijs, J
De Meirleir, K
Meeus, M
McGregor, NR
Englebienne, P
机构
[1] VUB, Dept Human Physiol, Fac Phys Educ & Phys Therapy Sci, B-1090 Brussels, Belgium
[2] Inst Occupat & Phys Therapy, Dept Hlth Sci, Hogeschool Antwerpen, Antwerp, Belgium
[3] VUB, Chron Fatigue Clin, Brussels, Belgium
[4] Univ Melbourne, Biomed Res Inst, Bio21, Melbourne, Vic 3000, Australia
[5] Westmead Hosp, Dent Clin Sch, Westmead, NSW, Australia
[6] Free Univ Brussels, Dept Nucl Med, Brussels, Belgium
[7] RED Labs NV, Zellik, Belgium
关键词
D O I
10.1016/j.mehy.2003.11.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The exacerbation of symptoms after exercise differentiates Chronic fatigue syndrome (CFS) from several other fatigue-associated disorders. Research data point to an abnormal response to exercise in patients with CFS compared to healthy sedentary controls, and to an increasing amount of evidence pointing to severe intracellular immune deregulations in CFS patients. This manuscript explores the hypothetical interactions between these two separately reported observations. First, it is explained that the deregulation of the 2-5A synthetase/RNase L pathway may be related to a channelopathy, capable of initiating both intracellular hypomagnesaemia in skeletal muscles and transient hypoglycemia. This might explain muscle weakness and the reduction of maximal oxygen uptake, as typically seen in CFS patients. Second, the activation of the protein kinase R enzyme, a characteristic feature in at least subsets of CFS patients, might account for the observed excessive nitric oxide (NO) production in patients with CFS. Elevated NO is known to induce vasidilation, which may limit CFS patients to increase blood flow during exercise, and may even cause and enhanced postexercise hypotension. Finally, it is explored how several types of infections, frequently identified in CFS patients, fit into these hypothetical pathophysiological interactions. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:759 / 765
页数:7
相关论文
共 73 条
  • [1] [Anonymous], 1998, J CHRONIC FATIGUE SY
  • [2] [Anonymous], 2003, J CHRONIC FATIGUE SY
  • [3] [Anonymous], J CHRONIC FATIGUE SY
  • [4] Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety
    Baseman, JB
    Tully, JG
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (01) : 21 - 32
  • [5] BAUM SC, 1995, PRINCIPLES PRACTICE, P1713
  • [6] COXSACKIE-B VIRUSES AND MYALGIC ENCEPHALOMYELITIS
    BELL, EJ
    MCCARTNEY, RA
    RIDING, MH
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1988, 81 (06) : 329 - 331
  • [7] DIVERSITY OF ANKYRINS IN THE BRAIN
    BENNETT, V
    OTTO, E
    KUNIMOTO, M
    KORDELI, E
    LAMBERT, S
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (04) : 1034 - 1039
  • [8] CLONING AND CHARACTERIZATION OF A RNASE-L INHIBITOR - A NEW COMPONENT OF THE INTERFERON-REGULATED 2-5A PATHWAY
    BISBAL, C
    MARTINAND, C
    SILHOL, M
    LEBLEU, B
    SALEHZADA, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) : 13308 - 13317
  • [9] The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation
    Bisbal, C
    Silhol, M
    Laubenthal, K
    Kaluza, T
    Carnac, G
    Milligan, L
    Le Roy, F
    Salehzada, T
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) : 4959 - 4969
  • [10] CASEY AK, 2001, J APPL PHYSIOL, V91, P2674